Peer-Review Record
Mesenchymal Stem Cells Therapies on Fibrotic Heart Diseases
Int. J. Mol. Sci. 2021, 22(14), 7447; https://doi.org/10.3390/ijms22147447
by
Fernanda Gubert 1,2
, Jaqueline Soares da Silva 3, Juliana F. Vasques 2,4, Renata Guedes de Jesus Gonçalves 2,4, Robertta Silva Martins 2,4, Mauro Paes Leme de Sá 5, Rosalia Mendez-Otero 2,4,*,† and Gisele Zapata-Sudo 3,5,*,†
, Jaqueline Soares da Silva 3, Juliana F. Vasques 2,4, Renata Guedes de Jesus Gonçalves 2,4, Robertta Silva Martins 2,4, Mauro Paes Leme de Sá 5, Rosalia Mendez-Otero 2,4,*,† and Gisele Zapata-Sudo 3,5,*,†Reviewer 1:
Anonymous
Reviewer 2:
Anonymous
Int. J. Mol. Sci. 2021, 22(14), 7447; https://doi.org/10.3390/ijms22147447
Submission received: 12 June 2021
/
Revised: 4 July 2021
/
Accepted: 5 July 2021
/
Published: 12 July 2021
(This article belongs to the Special Issue The Role of Mesenchymal Stem Cells on Inflammatory and Fibrotic Diseases)
Round 1
Reviewer 1 Report
This article would be very interesting and informative for specialists in the field of regenerative medicine and cardiology
Author Response
As suggested by reviewer, the text was checked for language errors and corrections were made.
Reviewer 2 Report
The authors have put together a detailed and extensive, yet focused, review on the topic of MSCs in heart repair. The manuscript deserves publication in this journal, and I recommend that the manuscript be accepted as is.
Author Response
As suggested by reviewer, the text was checked for language errors and corrections were made.
